Ran Nakashima Selected Research

Amyopathic dermatomyositis

9/2019	Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.
1/2016	Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody.
5/2013	The prognostic value of HRCT in myositis-associated interstitial lung disease.
6/2012	Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.
9/2010	Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
11/2007	Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ran Nakashima Research Topics

Disease

21	Dermatomyositis (Dermatopolymyositis) 11/2021 - 03/2010
17	Myositis (Idiopathic Inflammatory Myopathies) 02/2022 - 11/2007
17	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2021 - 09/2010
9	Rheumatoid Arthritis 11/2022 - 01/2017
7	Melanoma (Melanoma, Malignant) 01/2020 - 09/2010
6	Connective Tissue Diseases (Connective Tissue Disease) 10/2020 - 02/2014
6	Amyopathic dermatomyositis 09/2019 - 11/2007
5	Polymyositis 01/2017 - 02/2012
4	Fever (Fevers) 01/2021 - 08/2010
4	Disease Progression 11/2020 - 12/2016
3	Muscular Diseases (Myopathy) 01/2022 - 09/2018
3	Arthritis (Polyarthritis) 01/2022 - 06/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2014
3	Takayasu Arteritis (Arteritis, Takayasu's) 05/2021 - 01/2017
3	Neoplasms (Cancer) 09/2018 - 11/2007
2	digital ulcers 01/2022 - 07/2021
2	Inflammation (Inflammations) 01/2022 - 09/2017
2	Systemic Scleroderma (Systemic Sclerosis) 05/2015 - 09/2012
2	Myalgia 06/2011 - 08/2010
1	Neutropenia 11/2022
1	Microscopic Polyangiitis 01/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hyperplasia 01/2022
1	Gangrene 07/2021
1	Ischemia 07/2021
1	Necrosis 07/2021
1	Cytopenia 01/2021
1	Hypoxia (Hypoxemia) 11/2020
1	Central Nervous System Lupus Vasculitis 11/2020
1	Pneumonia (Pneumonitis) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 03/2017
1	Infections 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Granuloma 01/2017
1	Diabetes Insipidus 01/2017

Drug/Important Bio-Agent (IBA)

22	AntibodiesIBA 01/2022 - 11/2007
20	AutoantibodiesIBA 02/2022 - 11/2007
7	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 07/2021 - 01/2015
7	Biomarkers (Surrogate Marker)IBA 10/2020 - 02/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2012
6	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 06/2012
5	Ligases (Synthetase)IBA 01/2022 - 11/2007
4	AntigensIBA 01/2022 - 06/2011
4	AutoantigensIBA 01/2017 - 11/2007
4	EnzymesIBA 12/2014 - 08/2010
3	Immunoglobulin G (IgG)IBA 02/2022 - 05/2015
3	Signal Recognition ParticleIBA 01/2022 - 12/2016
3	Ferritins (Ferritin)IBA 11/2020 - 05/2013
3	GlucocorticoidsIBA 01/2020 - 08/2013
3	Transfer RNA (tRNA)IBA 01/2014 - 11/2007
2	HLA-DR Antigens (HLA-DR)IBA 02/2022 - 01/2022
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 09/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2014
2	CytokinesIBA 11/2020 - 01/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2012
2	InterleukinsIBA 09/2019 - 01/2017
2	Calcineurin InhibitorsIBA 01/2019 - 06/2012
2	Peptides (Polypeptides)IBA 06/2017 - 09/2010
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 01/2017
1	tocilizumab (atlizumab)FDA Link 11/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	fatostatinIBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Fc Receptors (Fc Receptor)IBA 01/2022
1	CholesterolIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	LipidsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	nuclear matrix protein 2IBA 11/2021
1	Jo-1 antibodyIBA 07/2021
1	Ustekinumab (CNTO 1275)FDA Link 05/2021
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020
1	Anti-Citrullinated Protein AntibodiesIBA 10/2020
1	cyclic citrullinated peptideIBA 10/2020
1	VimentinIBA 05/2020
1	AlbuminsIBA 03/2020
1	Peroxidase (Myeloperoxidase)IBA 03/2020
1	NeopterinIBA 09/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2019
1	Matrix Metalloproteinases (MMPs)IBA 03/2019
1	Nuclear Matrix-Associated ProteinsIBA 09/2018
1	Mi-2 antibodiesIBA 09/2018
1	Interleukin-2 (IL2)IBA 07/2018
1	Biological ProductsIBA 09/2017
1	Rheumatoid FactorIBA 06/2017
1	Oxygen (Dioxygen)IBA 03/2017
1	Glutamine (L-Glutamine)FDA Link 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2017

Therapy/Procedure

4	Therapeutics 01/2022 - 03/2017
2	Plasma Exchange 11/2020 - 01/2017
1	Remission Induction 09/2019